E
CLNN icon

Ergoteles’s Clene CLNN Stock Holding History

Ergoteles’s Portfolio CLNN Stock Details CLNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,259
Closed -$416K – 1602
2022
Q2 		$416K Buy
+8,259
New +$461K 0.01% 922

Other funds holding CLNN

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIA
Soltis Investment Advisors St. George, Utah $1.8B AUM 27.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

Ergoteles's CLNN Position: Q3 2022 in Review

Ergoteles sold out of Clene (CLNN) in Q3 2022, closing a stake of 8,259 shares — an estimated $416K sold.

Ergoteles first reported a position in CLNN in Q2 2022 and held it in 1 quarter. The position peaked at $416K in Q2 2022. 38 funds tracked by Wall St. Rank hold CLNN as of Q3 2022.

  • Ergoteles reported no remaining Clene position as of Q3 2022 after selling out during the quarter.
  • Ergoteles sold 8,259 Clene shares in Q3 2022, an estimated $416K.
  • Ergoteles first reported a position in Clene in Q2 2022 and held it in 1 quarter.
  • Ergoteles's Clene position peaked at $416K in Q2 2022.
  • 38 funds tracked by Wall St. Rank held Clene as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.